These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 760684)

  • 1. Detection and treatment of occupational lead nephropathy.
    Wedeen RP; Malik DK; Batuman V
    Arch Intern Med; 1979 Jan; 139(1):53-7. PubMed ID: 760684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of chelation therapy in lead nephropathy.
    Germain MJ; Braden GL; Fitzgibbons JP
    Arch Intern Med; 1984 Dec; 144(12):2419-20. PubMed ID: 6439141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["Terzo fuoco", lead poisoning and chronic renal failure].
    Bonucchi D; Mondaini G; Ravera F; Minisci E; Albertazzi V; Arletti S; Mori G; Ballestri M; Piattoni J; Cappelli G
    G Ital Nefrol; 2007; 24 Suppl 38():76-9. PubMed ID: 17922453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case of lead nephropathy due to chronic occupational lead exposure].
    Ogata A; Sueta S; Tagawa M
    Nihon Jinzo Gakkai Shi; 2011; 53(2):207-11. PubMed ID: 21516708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
    Lin-Tan DT; Lin JL; Yen TH; Chen KH; Huang YL
    Nephrol Dial Transplant; 2007 Oct; 22(10):2924-31. PubMed ID: 17556414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lead poisoning: a "forgotten" cause of renal disease.
    Benjelloun M; Tarrass F; Hachim K; Medkouri G; Benghanem MG; Ramdani B
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):83-6. PubMed ID: 17237897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult chronic lead intoxication. A clinical review.
    Balestra DJ
    Arch Intern Med; 1991 Sep; 151(9):1718-20. PubMed ID: 1888236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate.
    Sánchez-Fructuoso AI; Blanco J; Cano M; Ortega L; Arroyo M; Fernández C; Prats D; Barrientos A
    Am J Kidney Dis; 2002 Jul; 40(1):59-67. PubMed ID: 12087562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic nephropathy in saturnism. Comparative elimination of lead by classic chelating agents and peritoneal dialysis].
    Mirouze J; Mion C; Mathieu-Daude P; Monnier L; Selam JL
    Nouv Presse Med; 1975 May; 4(22):1642-4. PubMed ID: 1215179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lead and the kidney: nephropathy, hypertension, and gout.
    Perazella MA
    Conn Med; 1996 Sep; 60(9):521-6. PubMed ID: 8908777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-level environmental exposure to lead and progressive chronic kidney diseases.
    Lin JL; Lin-Tan DT; Li YJ; Chen KH; Huang YL
    Am J Med; 2006 Aug; 119(8):707.e1-9. PubMed ID: 16887418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible nephrotoxic reactions to a combined 2,3-dimercapto-1-propanol and calcium disodium ethylenediaminetetraacetic acid regimen in asymptomatic children with elevated blood lead levels.
    Moel DI; Kumar K
    Pediatrics; 1982 Aug; 70(2):259-62. PubMed ID: 7099793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral protein load on urinary protein excretion in workers exposed to cadmium and to lead.
    Hotz P; Mujyabwami F; Roels H; Bernard AM; Lauwerys RR
    Am J Ind Med; 1996 Feb; 29(2):195-200. PubMed ID: 8821363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of renal function of workers simultaneously exposed to inorganic lead and cadmium.
    Buchet JP; Roels H; Bernard A; Lauwerys R
    J Occup Med; 1981 May; 23(5):348-52. PubMed ID: 7241248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute renal failure in the course of occupational lead intoxication. Chelation therapy responsability (author's transl)].
    Yver L; Maréchaud R; Picaud D; Touchard G; d'Eyzac AT; Matuchansky C; Patte D
    Nouv Presse Med; 1978 May; 7(18):1541-3. PubMed ID: 97624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is lead chelation therapy effective for chronic kidney disease? A meta-analysis.
    Yang SK; Xiao L; Song PA; Xu XX; Liu FY; Sun L
    Nephrology (Carlton); 2014 Jan; 19(1):56-9. PubMed ID: 24341661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acetyl glucosaminidase excretion in exposure to lead].
    Poór G; Groszmann M; Ujvári A; Jósfay L; Mituszova M
    Orv Hetil; 1987 Dec; 128(49):2587-90. PubMed ID: 3438082
    [No Abstract]   [Full Text] [Related]  

  • 19. Occult lead intoxication in patients with gout and kidney disease.
    Wright LF; Saylor RP; Cecere FA
    J Rheumatol; 1984 Aug; 11(4):517-20. PubMed ID: 6434739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult lead poisoning.
    Zatlin GS; Senaldi EM; Bruckheim AH
    Am Fam Physician; 1985 Oct; 32(4):137-43. PubMed ID: 3931445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.